ABSTRACT
Extraction strategies impact the efficiency and nature of extracted compounds. This work assessed the chemical composition and antioxidant capacity of ethanolic, hydroethanolic, and aqueous versus enzyme-assisted extracts (isolated or with the sequential use of alcalase®, cellulase®, and viscozyme®) of the macroalgae Fucus vesiculosus (brown, Phaeophyceae) and Porphyra dioica (red, Rhodophyta. For both macroalgae, enzyme-assisted extraction (EAE) was the most efficient process compared to solvent-assisted extraction (SAE), independent of solvent. Fucus vesiculosus extraction yields were higher for EAE than for SAE (27.4% to 32.2% and 8.2% to 30.0%, respectively). Total phenolics content (TPC) was at least 10-fold higher in EAE extracts (229.2 to 311.3 GAE/gextract) than in SAE (4.34 to 19.6 GAE/gextract) counterparts and correlated well with antioxidant capacity (ABTS and ORAC methods), with EAE achieving values up to 8- and 2.6-fold higher than those achieved by SAE, respectively. Porphyra dioica followed F. vesiculosus's trend for extraction yields (37.5% to 51.6% for EAE and 5.7% to 35.1% for SAE), TPC, although of a lower magnitude, (0.77 to 8.95 GAE/gextract for SE and 9.37 to 14.73 GAE/gextract for EAE), and antioxidant capacity. Aqueous extracts registered the highest DPPH values for both macroalgae, with 2.3 µmol TE/gextract and 13.3 µmol TE/gextract for F. vesiculosus and P. dioica, respectively. EAE was a more efficient process in the extraction of soluble protein and reducing sugars in comparison to SAE. Furthermore, an improved effect of enzyme-assisted combinations was observed for almost all analyzed parameters. This study shows the promising application of enzyme-assisted extraction for the extraction of valuable compounds from F. vesiculosus and P.dioica, making them excellent functional ingredients for a wide range of health and food industrial applications.
Subject(s)
Antioxidants , Fucus , Porphyra , Seaweed , Solvents , Fucus/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry , Antioxidants/isolation & purification , Porphyra/chemistry , Solvents/chemistry , Seaweed/chemistry , Phenols/chemistry , Phenols/isolation & purification , Phenols/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacologyABSTRACT
A Gram-negative, aerobic, pink-pigmented, and bacteriochlorophyll a-containing bacterial strain, designated B14T, was isolated from the macroalga Fucus spiralis sampled from the southern North Sea, Germany. Based on 16S rRNA gene sequences, species of the genera Roseobacter and Sulfitobacter were most closely related to strain B14T with sequence identities ranging from 98.15â% (Roseobacter denitrificans Och 114T) to 99.11â% (Roseobacter litoralis Och 149T), whereas Sulfitobacter mediterraneus CH-B427T exhibited 98.52â% sequence identity. Digital DNA-DNA hybridization and average nucleotide identity values between the genome of the novel strain and that of closely related Roseobacter and Sulfitobacter type strains were <20â% and <77â%, respectively. The novel strain contained ubiquinone-10 as the only respiratory quinone and C18â:â1 ω7c, C16â:â0, C18â:â0, C12â:â1 ω7c, C18â:â2 ω7,13c, and C10â:â0 3-OH as the major cellular fatty acids. The predominant polar lipids of strain B14T were phosphatidylcholine, phosphatidylethanolamine, and phosphatidylglycerol. The genome of strain B14T comprises a chromosome with a size of 4.5 Mbp, one chromid, and four plasmids. The genome contains the complete gene cluster for aerobic anoxygenic photosynthesis required for a photoheterotrophic lifestyle. The results of this study indicate that strain B14T (=DSM 116946T=LMG 33352T) represents a novel species of the genus Roseobacter for which the name Roseobacter fucihabitans sp. nov. is proposed.
Subject(s)
Bacterial Typing Techniques , Base Composition , DNA, Bacterial , Fatty Acids , Fucus , Nucleic Acid Hybridization , Phylogeny , RNA, Ribosomal, 16S , Roseobacter , Sequence Analysis, DNA , Ubiquinone , RNA, Ribosomal, 16S/genetics , Roseobacter/genetics , Roseobacter/classification , Roseobacter/isolation & purification , Fatty Acids/chemistry , DNA, Bacterial/genetics , Fucus/microbiology , Germany , North Sea , Genome, Bacterial , Phospholipids , Bacteriochlorophyll AABSTRACT
BACKGROUND: Brown seaweed is promising for the treatment of type 2 diabetes mellitus (T2DM). Its bioactive constituents can positively affect plasma glucose homeostasis in healthy humans. We investigated the effect of the brown seaweeds Sargassum (S.) fusiforme and Fucus (F.) vesiculosus in their natural form on glucose regulation in patients with T2DM. METHODS: We conducted a randomized, double-blind, placebo-controlled pilot trial. Thirty-six participants with T2DM received, on a daily basis, either 5 g of dried S. fusiforme, 5 g of dried F. vesiculosus, or 0.5 g of dried Porphyra (control) for 5 weeks, alongside regular treatment. The primary outcome was the between-group difference in the change in weekly average blood glucose levels (continuous glucose monitoring). The secondary outcomes were the changes in anthropometrics, plasma lipid levels, and dietary intake. The data were analyzed using a linear mixed-effects model. RESULTS: The change in weekly average glucose levels was 8.2 ± 2.1 to 9.0 ± 0.7 mmol/L (p = 0.2) in the S. fusiforme group (n = 12) and 10.1 ± 3.3 to 9.2 ± 0.7 mmol/L (p = 0.9) in the F. vesiculosus group (n = 10). The between-group difference was non-significant. Similarly, no between-group differences were observed for the changes in the secondary outcomes. DISCUSSION: A daily intake of 5 g of fresh, dried S. fusiforme or F. vesiculosus alongside regular treatment had no differential effect on weekly average blood glucose levels in T2DM.
Subject(s)
Blood Glucose , Diabetes Mellitus, Type 2 , Fucus , Sargassum , Humans , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Double-Blind Method , Blood Glucose/metabolism , Blood Glucose/drug effects , Male , Female , Middle Aged , Fucus/chemistry , Pilot Projects , Overweight/blood , Feasibility Studies , Aged , Adult , Seaweed , Hypoglycemic Agents/therapeutic use , Hypoglycemic Agents/pharmacology , Edible SeaweedsABSTRACT
In this study, an acidic polysaccharide (FVP-7 A) was isolated from Fucus vesiculosus by DEAE-Sepharose™ fast flow. The chemical composition, glycosidic bonds and in vitro fecal fermentation characteristics of FVP-7 A were studied. Results shown that FVP-7 A was a homogenous polysaccharide with average molecular weight of 30.94 kDa. Combined with FT-IR, monosaccharide composition, methylation and NMR analysis, the glycosidic bonds of FVP-7 A mainly composed of â4)-ß-D-Manp-(1â, â3)-α-L-Fucp-(1â, α-D-Manp-(1â, â3)-ß-D-Manp-(1 â and â4,6)-α-D-Manp-(1â. The zeta potential and atomic force microscopy images indicated that FVP-7 A could exist stably as a single chain-like structure in dilute solution. After gut fermentation, FVP-7 A was utilized and promoted multiple short-chain fatty acids production, especially acetic acid, butyric acid and valeric acid. For prebiotics, FVP-7 A significantly increased the relative abundance of short-chain fatty acids producing bacteria such as Bacteroides, Lachnospira, Faecalibacterium, Ruminococcus, Oscillospira and Dialister, and inhiited the growth of the harmful bacteria Shigella. These results indicated that FVP-7 A could be used as a potential dietary supplement to improve intestinal health.
Subject(s)
Fermentation , Fucus , Gastrointestinal Microbiome , Polysaccharides , Polysaccharides/chemistry , Polysaccharides/pharmacology , Humans , Fucus/chemistry , Fatty Acids, Volatile/metabolism , Molecular Weight , Prebiotics , Feces/microbiology , Monosaccharides/analysis , MethylationABSTRACT
Brown seaweeds of the Fucus genus represent a rich source of natural antiviral products. In this study, a Fucus ceranoides hydroalcoholic extract (FCHE) was found to inhibit 74.2 ± 1.3% of the proteolytic activity of the free SARS-CoV-2 3CL protease (3CLpro), an enzyme that plays a pivotal role in polyprotein processing during coronavirus replication and has been identified as a relevant drug discovery target for SARS- and MERS-CoVs infections. To purify and identify 3CLpro ligands with potential inhibitory activity using a one-step approach, we immobilized the enzyme onto magnetic microbeads (3CLpro-MPs), checked that the enzymatic activity was maintained after grafting, and used this bait for a ligand-fishing strategy followed by a high-resolution mass spectrometry analysis of the fished-out molecules. Proof of concept for the ligand-fishing capacity of the 3CLpro-MPs was demonstrated by doping the FCHE extract with the substrate peptide TSAVLQ-pNA, resulting in the preferential capture of this high-affinity peptide within the macroalgal complex matrix. Ligand fishing in the FCHE alone led to the purification and identification via high-resolution mass spectrometry (HRMS) of seven hepta-, octa-, and decapeptides in an eluate mix that significantly inhibited the free 3CLpro more than the starting FCHE (82.7 ± 2.2% inhibition). Molecular docking simulations of the interaction between each of the seven peptides and the 3CLpro demonstrated a high affinity for the enzyme's proteolytic active site surpassing that of the most affine peptide ligand identified so far (a co-crystallographic peptide). Testing of the corresponding synthetic peptides demonstrated that four out of seven significantly inhibited the free 3CLpro (from 46.9 ± 6.4 to 76.8 ± 3.6% inhibition at 10 µM). This study is the first report identifying peptides from Fucus ceranoides with high inhibitory activity against the SARS-CoV-2 3CLprotease which bind with high affinity to the protease's active site. It also confirms the effectiveness of the ligand-fishing strategy for the single-step purification of enzyme inhibitors from complex seaweed matrices.
Subject(s)
Antiviral Agents , Coronavirus 3C Proteases , Fucus , Protease Inhibitors , Coronavirus 3C Proteases/antagonists & inhibitors , Coronavirus 3C Proteases/metabolism , Antiviral Agents/pharmacology , Antiviral Agents/chemistry , Antiviral Agents/isolation & purification , Ligands , Fucus/chemistry , Protease Inhibitors/pharmacology , Protease Inhibitors/chemistry , Protease Inhibitors/isolation & purification , SARS-CoV-2/drug effects , SARS-CoV-2/enzymology , Plant Extracts/pharmacology , Plant Extracts/chemistry , Peptides/pharmacology , Peptides/chemistry , Molecular Docking Simulation , Humans , Seaweed/chemistryABSTRACT
In this study, different extraction methods and conditions were used for the extraction of antioxidants from brown macroalgae Fucus spiralis. The extraction methodologies used were ultrasound-assisted extraction (ultrasonic bath and ultrasonic probe), extraction with a vortex, extraction with an Ultra-Turrax® homogenizer, and high-pressure-assisted extraction. The extracts were analyzed for their total phenolic content (TPC) and their antioxidant activity, and evaluated through the 2,2-difenil-1-picrilhidrazil (DPPH) free radical scavenging method and ferric reducing antioxidant power (FRAP) assay. Ultrasonic probe-assisted extraction yielded the highest values of TPC (94.78-474.16 mg gallic acid equivalents/g extract). Regarding the antioxidant activity, vortex-assisted extraction gave the best DPPH results (IC50 1.89-16 µg/mL), while the highest FRAP results were obtained using the Ultra-Turrax® homogenizer (502.16-1188.81 µmol ascorbic acid equivalents/g extract). For each extraction method, response surface methodology was used to analyze the influence of the experimental conditions "extraction time" (t), "biomass/solvent ratio" (R), "solvent" (S, water % in water/ethanol mixture), and "pressure" (P) on TPC, DPPH, and FRAP of the F. spiralis extracts. In general, higher TPC content and higher antioxidant capacity (lower IC50 and higher FRAP) were obtained with higher R, t, and P, and lower S (higher ethanol %). The model regarding the combined effects of independent variables t, R, and S on the FRAP response values for vortex-assisted extractions best fitted the experimental data (R2 0.957), with optimal extraction conditions of t = 300 s, R = 50 g, and S = 25%.
Subject(s)
Antioxidants , Fucus , Fucus/chemistry , Antioxidants/chemistry , Antioxidants/pharmacology , Antioxidants/isolation & purification , Phenols/chemistry , Phenols/isolation & purification , Phenols/analysis , Seaweed/chemistry , Biphenyl Compounds/chemistry , Biphenyl Compounds/antagonists & inhibitors , Picrates/chemistry , Picrates/antagonists & inhibitors , Solvents/chemistryABSTRACT
Enzymatic degradation of algae cell wall carbohydrates by microorganisms is under increasing investigation as marine organic matter gains more value as a sustainable resource. The fate of carbon in the marine ecosystem is in part driven by these degradation processes. In this study, we observe the microbiome dynamics of the macroalga Fucus vesiculosus in 25-day-enrichment cultures resulting in partial degradation of the brown algae. Microbial community analyses revealed the phylum Pseudomonadota as the main bacterial fraction dominated by the genera Marinomonas and Vibrio. More importantly, a metagenome-based Hidden Markov model for specific glycosyl hydrolyses and sulphatases identified Bacteroidota as the phylum with the highest potential for cell wall degradation, contrary to their low abundance. For experimental verification, we cloned, expressed, and biochemically characterised two α-L-fucosidases, FUJM18 and FUJM20. While protein structure predictions suggest the highest similarity to a Bacillota origin, protein-protein blasts solely showed weak similarities to defined Bacteroidota proteins. Both enzymes were remarkably active at elevated temperatures and are the basis for a potential synthetic enzyme cocktail for large-scale algal destruction.
Subject(s)
Cell Wall , Fucus , Metagenomics , Cell Wall/metabolism , Fucus/metabolism , Fucus/genetics , Fucus/microbiology , Metagenomics/methods , Bacteroidetes/genetics , Bacteroidetes/enzymology , Metagenome , Microbiota , PhylogenyABSTRACT
High blood cholesterol levels are a major risk factor for cardiovascular diseases. A purified aqueous extract of Fucus vesiculosus, rich in phlorotannins and peptides, has been described for its potential to inhibit cholesterol biosynthesis and intestinal absorption. In this work, the effect of this extract on intestinal cells' metabolites and proteins was analysed to gain a deeper understanding of its mode of action on lipids' metabolism, particularly concerning the absorption and transport of exogenous cholesterol. Caco-2 cells, differentiated into enterocytes, were exposed to the extract, and analysed by untargeted metabolomics and proteomics. The results of the metabolomic analysis showed statistically significant differences in glutathione content of cells exposed to the extract compared to control cells, along with an increased expression of fatty acid amides in exposed cells. A proteomic analysis showed an increased expression in cells exposed to the extract compared to control cells of FAB1 and NPC1, proteins known to be involved in lipid metabolism and transport. To the extent of our knowledge, this study is the first use of untargeted metabolomics and a proteomic analysis to investigate the effects of F. vesiculosus on differentiated Caco-2 cells, offering insights into the molecular mechanism of the extract's compounds on intestinal cells.
Subject(s)
Fucus , Proteomics , Humans , Caco-2 Cells , Fucus/chemistry , Proteomics/methods , Anticholesteremic Agents/pharmacology , Lipid Metabolism/drug effects , Metabolomics , Cholesterol/metabolism , Intestinal Absorption/drug effects , Plant Extracts/pharmacology , Intestines/drug effectsABSTRACT
BACKGROUND: Snakebite envenomation (SBE) causes diverse toxic effects in humans, including disability and death. Current antivenom therapies effectively prevent death but fail to block local tissue damage, leading to an increase in the severity of envenomation; thus, seeking alternative treatments is crucial. METHODS: This study analyzed the potential of two fucoidan sulfated polysaccharides extracted from brown seaweeds Fucus vesiculosus (FVF) and Undaria pinnatifida (UPF) against the fibrinogen or plasma coagulation, proteolytic, and phospholipase A2 (PLA2) activities of Bothrops jararaca, B. jararacussu, and B. neuwiedi venom. The toxicity of FVF and UPF was assessed by the hemocompatibility test. RESULTS: FVF and UPF did not lyse human red blood cells. FVF and UPF inhibited the proteolytic activity of Bothrops jararaca, B. jararacussu, and B. neuwiedi venom by approximately 25%, 50%, and 75%, respectively, while all venoms led to a 20% inhibition of PLA2 activity. UPF and FVF delayed plasma coagulation caused by the venoms of B. jararaca and B. neuwiedi but did not affect the activity of B. jararacussu venom. FVF and UPF blocked the coagulation of fibrinogen induced by all these Bothropic venoms. CONCLUSION: FVF and UPF may be of importance as adjuvants for SBE caused by species of Bothrops, which are the most medically relevant snakebite incidents in South America, especially Brazil.
Subject(s)
Blood Coagulation , Crotalid Venoms , Fucus , Phospholipases A2 , Polysaccharides , Undaria , Animals , Antivenins/pharmacology , Blood Coagulation/drug effects , Bothrops , Bothrops jararaca , Crotalid Venoms/toxicity , Crotalid Venoms/enzymology , Edible Seaweeds/chemistry , Fucus/chemistry , Phospholipases A2/metabolism , Polysaccharides/pharmacology , Polysaccharides/isolation & purification , Proteolysis/drug effects , Seaweed/chemistry , Undaria/chemistry , Venomous SnakesABSTRACT
Polyphenols (PP) found in brown algae are known for their wide range of biological activities including noteworthy antitumor properties. This article presents a method for obtaining an active polyphenolic extract from the Arctic alga Fucus vesiculosus with 98% purity and radical scavenging activity equivalent to 862 mg of ascorbic acid per gram of extract. Immunostimulant effects of polyphenols were assessed in vitro using venous blood from two groups of people: healthy people (HP) and people with chronic undifferentiated lymphocytic leukemia (LP). Polyphenols activated the surface properties of immunocompetent cells. Specifically, polyphenols dose-dependently increased the percentage of cells' spreading and adhesion by 2-3 times. Additionally, polyphenols increased the number of activated lymphocytes in the LP blood to levels characteristic of HP. Given their natural origin, high activity, non-toxicity, and straightforward production process, these studied polyphenols exhibit immense potential for use as new pharmaceuticals or as active components with immunostimulatory effects.
Subject(s)
Adjuvants, Immunologic , Fucus , Polyphenols , Polyphenols/pharmacology , Fucus/chemistry , Humans , Adjuvants, Immunologic/pharmacology , Lymphocytes/drug effects , Plant Extracts/pharmacologyABSTRACT
Fucoidan has attracted considerable attention from scientists and pharmaceutical companies due to its antioxidant, anticoagulant, anti-inflammatory, anti-tumor, and health-enhancing properties. However, the extraction of fucoidan from seaweeds often involves the use of harsh chemicals, which necessitates the search for alternative solvents. Additionally, the high viscosity and low cell permeability of high molecular weight (Mw) fucoidan can limit its effectiveness in drug action, while lower Mw fractions exhibit increased biological activity and are also utilized as dietary supplements. The study aimed to (1) extract fucoidan from the seaweed Fucus vesiculosus (FV) using an environmentally friendly solvent and compare it with the most commonly used extraction solvent, hydrochloric acid, and (2) assess the impact of ultrasound-assisted depolymerization on reducing the molecular weight of the fucoidan extracts and examine the cytotoxic effect of different molecular weight fractions. The findings indicated that the green depolymerization solvent, in conjunction with a brief ultrasound treatment, effectively reduced the molecular weight. Moreover, a significant decrease in cell viability was observed in selected samples, indicating potential anticancer properties. As a result, ultrasound was determined to be an effective method for depolymerizing crude fucoidan from Fucus Vesiculosus seaweed.
Subject(s)
Fucus , Polysaccharides , Seaweed , Seaweed/chemistry , Fucus/chemistry , Anticoagulants , SolventsABSTRACT
To evaluate seaweed as a biomonitoring organism, Fucus was sampled in the Faroe Islands. Nineteen PAHs, including the EPA 16, and four groups of alkylated PAHs were quantified using GC-MS analysis of extracts obtained using a modified QuEchERS method with ultrasonication in acetonitrile, back-extraction into hexane, and Florisil® cleanup. Samples from the harbor of Tórshavn collected at high tide were the most polluted with PAH concentrations between 1.3 × 102 and 1.7 × 102 ng/g wet weight. All samples contained a factor 10 higher concentrations of alkylated PAHs compared to their parent compounds. These results suggest that Fucus might be suitable as a biomonitoring organism for PAH pollution. Differences between samples collected in close proximity and on different days were observed (same range of RSD 14-120% and 60-102%, respectively), suggesting that water exchange, tide levels, and direct exposure to surface diesel pollution have a strong influence on pollutant uptake in Fucus. The findings stress the need for further evaluation of the sampling strategy.
Subject(s)
Biological Monitoring , Environmental Monitoring , Fucus , Polycyclic Aromatic Hydrocarbons , Water Pollutants, Chemical , Polycyclic Aromatic Hydrocarbons/analysis , Water Pollutants, Chemical/analysis , Environmental Monitoring/methods , Seaweed/chemistry , Islands , Gas Chromatography-Mass SpectrometryABSTRACT
BACKGROUND: The drive towards ensuring the sustainability of bioresources has been linked with better valorising primary materials and developing biorefinery pipelines. Seaweeds constitute valuable coastal resources with applications in the bioenergy, biofertiliser, nutrition, pharmaceutical and cosmetic sectors. Owing to the various sought-after metabolites they possess, several seaweed species are commercially exploited throughout Western Europe, including Ireland. Here, four commercially relevant brown (Fucus serratus and Fucus vesiculosus) and red (Chondrus crispus and Mastocarpus stellatus) seaweed species were sampled during a spring tide in July 2021 on moderately exposed shores across three coastal regions in the west of Ireland. RESULTS: Significant regional differences were identified when specimens were analysed for carbohydrates (max. 80.3 µg glucose eq mg-1 DW), proteins (max. 431.3 µg BSA eq. mg-1 DW), lipids (max. 158.6 mg g-1 DW), pigment signature and antioxidant potential. Protein content for F. serratus recorded a twofold difference between northern and southern specimens. The antioxidant potential of F. vesiculosus and M. stellatus returned greater activity compared to F. serratus and C. crispus, respectively. Multivariate analysis showed a clear latitudinal pattern across the three western coastal regions (north, west and south) for both F. vesiculosus and F. serratus. CONCLUSION: F. vesiculosus thalli from the northwest were richer in pigment content while the F. serratus thalli from the northwest were richer in antioxidants. Such biogeographic patterns in the biochemical make-up of seaweeds need consideration for the development of regional integrated aquaculture systems and the optimisation of the biomass content for targeted downstream applications. © 2024 Society of Chemical Industry.
Subject(s)
Antioxidants , Fucus , Seaweed , Seaweed/chemistry , Seaweed/metabolism , Antioxidants/analysis , Antioxidants/chemistry , Fucus/chemistry , Chondrus/chemistry , Ireland , Europe , Lipids/analysis , Lipids/chemistry , Carbohydrates/analysis , Carbohydrates/chemistryABSTRACT
Osteosarcoma is a bone cancer primarily affecting teenagers. It has a poor prognosis and diminished quality of life after treatment due to chemotherapy side effects, surgical complications and post-surgical osteoporosis risks. The sulphated polysaccharide fucoidan, derived from brown algae, has been a subject of interest for its potential anti-cancer properties and its impact on bone regeneration. This study explores the influence of crude, low-molecular-weight (LMW, 10-50 kDa), medium-molecular-weight (MMW, 50-100 kDa) and high-molecular-weight (HMW, >100 kDa) fractions from Sargassum filipendula, harvested from the Colombian sea coast, as well as crude fucoidan from Fucus vesiculosus, on a specific human osteoprogenitor cell type, human embryonic-derived mesenchymal stem cells. Fourier transform infrared spectroscopy coupled with attenuated total reflection (FTIR-ATR) results showed the highest sulphation levels and lowest uronic acid content in crude extract from F. vesiculosus. There was a dose-dependent drop in focal adhesion formation, proliferation and osteogenic differentiation of cells for all fucoidan types, but the least toxicity was observed for LMW and MMW. Transmission electron microscopy (TEM), JC-1 (5,50,6,60-tetrachloro-1,10,3,30-tetraethylbenzimi-dazolylcarbocyanine iodide) staining and cytochrome c analyses confirmed mitochondrial damage, swollen ER and upregulated autophagy due to fucoidans, with the highest severity in the case of F. vesiculosus fucoidan. Stress-induced apoptosis-like cell death by F. vesiculosus fucoidan and stress-induced necrosis-like cell death by S. filipendula fucoidans were also confirmed. LMW and MMW doses of <200 ng/mL were the least toxic and showed potential osteoinductivity. This research underscores the multifaceted impact of fucoidans on osteoprogenitor cells and highlights the delicate balance between potential therapeutic benefits and the challenges involved in using fucoidans for post-surgery treatments in patients with osteosarcoma.
Subject(s)
Filipendula , Fucus , Osteosarcoma , Sargassum , Humans , Adolescent , Sargassum/chemistry , Fucus/chemistry , Osteogenesis , Quality of Life , Polysaccharides/pharmacology , Polysaccharides/chemistry , Osteosarcoma/drug therapyABSTRACT
Em consequencia do aumento da esperança média de vida, o impacto do envelhecimento tem assumido um interesse gradualment crescente. A pele asume um papel central, refletindo os primeiros sinais de envelhecimento como rugas, deshidrataçao, perda de luminosidade e de firmeza. No sentido de preservar uma boa aparencia, a procura de productos com açao na prevençao e tratamento do envelhecimento da pele tam aumentado. Por sua vez, a dermocosmética tem incluído cada vez mais nas suas formulaçoes ingredientes à base de plantas, que tem demonstrado diversas propiedades com muito interesse nesta área. Assim, este artigo tem como abjetivo nao só abordar o tema envelhecimento da pele como também fazer uma revisao sobre os beneficios de algunas plantas, algas e seus metabolitos, nomeadamente, Aloe barbadensis, Argania spinosa, Calendula officinalis, Camellia sinensis, Fucus vesiculosus, Glycine max e Vitis vinífera (AU)
Como resultado del aumento de la esperanza de vida, el impacto del envejecimiento como las arrugas, deshidratació, pérdida de luminosidad y firmeza. A fin de mantener una buena apariencia, ha aumentado la demanda de productos con acción en la prevención y el tratamiento de envejecimiento de la piel. A su vez, la dermocosmética ha incluido cada vez ás en sus formulaciones ingredientes vegetales que han demostrado tener propiedades de interés en esta área. Este artículo pretende abordar no sólo la piel tema de envejecimiento, sino también revisar los beneficios de algunas plantas, algas y sus metabolitos, en particular: Aloe barbadensis, Argania spinosa, Caléndula officinalis, Camelia sinensis, Fucus vesiculosus, Glycine max y Vitis vinífera (AU)
As a results of the increase of the life expectancy, the impact of aging has assumed an increasingly growing interest. The skin plays a central role, reflecting the first signs of aging such as wrinkles, dry skin, blemishes, loss of luminosity and firmness. To preserve a good appearance, the demand of products with action in their prevention and treatment has increased. In turn, the dermocosmetic has increasingly included in their formulations herbal ingredients that have demonstrated various properties with great interest in this area. This article aims to make an approach to the skin aging subjects as well as to review the benefits of plants algae and their metabolites, including Aloa Barbadensis, Argania spinose, Calendula officinalis, Camelia sinensis, Fucus vesiculosus, Glycine max and Vitis vinifera (AU)
Subject(s)
Humans , Male , Female , Skin Aging , Skin Aging/physiology , Phytotherapy , Dehydration/therapy , Aloe , 26215/therapeutic use , Camellia sinensis , Fucus/therapeutic use , Glycine max , Skin/anatomy & histology , Life Expectancy/trends , Vitis , Phytotherapy/methods , Skin Aging/radiation effectsABSTRACT
Fucoidan is a sulfated polysaccharide derived from brown seaweed, including Fucus vesiculosus. This compound is known to have immunostimulatory effects on various types of immune cells including macrophages and dendritic cells. A recent study described the application of fucoidan as a vaccine adjuvant. Vaccination is regarded as the most efficient prophylactic method for preventing harmful or epidemic diseases. To increase vaccine efficacy, effective adjuvants are needed. In the present study, we determined whether fucoidan can function as an adjuvant using vaccine antigens. Flow cytometric analysis revealed that fucoidan increases the expression of the activation markers major histocompatibility complex class II, cluster of differentiation (CD)25, and CD69 in spleen cells. In combination with Bordetella bronchiseptica antigen, fucoidan increased the viability and tumor necrosis factor-alpha production of spleen cells. Furthermore, fucoidan increased the in vivo production of antigen-specific antibodies in mice inoculated with Mycoplasma hyopneumoniae antigen. Overall, this study has provided valuable information about the use of fucoidan as a vaccine adjuvant.
Subject(s)
Animals , Female , Mice , Adjuvants, Immunologic/pharmacology , Antigens, Bacterial/immunology , Bacterial Vaccines/administration & dosage , Biomarkers/metabolism , Bordetella bronchiseptica/immunology , Cells, Cultured , Cytokines/metabolism , Flow Cytometry , Fucus/chemistry , Gene Expression Regulation/drug effects , Mice, Inbred BALB C , Mycoplasma hyopneumoniae/immunology , Polysaccharides/pharmacology , Spleen/metabolismABSTRACT
Fucoidan is an active component of seaweed, which inhibits proliferation and induces apoptosis of several tumor cells while the detailed mechanisms underlying this process are still not clear. In this study, the effect of Fucoidan on the proliferation and apoptosis of human breast cancer MCF-7 cells and the molecular mechanism of Fucoidan action were investigated. Viable cell number of MCF-7 cells was decreased by Fucoidan treatment in a dose-dependent manner as measured by MTT assay. Fucoidan treatment resulted in G1 phase arrest of MCF-7 cells as revealed by flow cytometry, which was associated with the decrease in the gene expression of cyclin D1 and CDK-4. Annexin V/PI staining results showed that the number of apoptotic cells was associated with regulation of cytochrome C, caspase-8, Bax and Bcl-2 at transcriptional and translational levels. Both morphologic observation and Hoechst 33258 assay results confirmed the pro-apoptotic effect of Fucoidan. Meanwhile, the ROS production was also increased by Fucoidan treatment, which suggested that Fucoidan induced oxidative damage in MCF-7 cells. The results of present study demonstrated that Fucoidan could induce G1 phase arrest and apoptosis in MCF-7 cells through regulating the cell cycle and apoptosis-related genes or proteins expression, and ROS generation is also involved in these processes.
Subject(s)
Humans , Antineoplastic Agents , Chemistry , Pharmacology , Apoptosis , Genetics , Blotting, Western , Breast Neoplasms , Genetics , Metabolism , Pathology , Caspase 8 , Genetics , Metabolism , Caspases , Genetics , Metabolism , Cell Proliferation , Cell Size , Cyclin D1 , Genetics , Metabolism , Cyclin-Dependent Kinase 4 , Genetics , Metabolism , Cytochromes c , Genetics , Metabolism , Dose-Response Relationship, Drug , Fucus , Chemistry , G1 Phase Cell Cycle Checkpoints , Genetics , Gene Expression Regulation, Neoplastic , MCF-7 Cells , Microscopy, Fluorescence , Molecular Structure , Polysaccharides , Chemistry , Pharmacology , Proto-Oncogene Proteins c-bcl-2 , Genetics , Metabolism , Reactive Oxygen Species , Metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , bcl-2-Associated X Protein , Genetics , MetabolismABSTRACT
Introducción. El Fucus vesiculosus es una alga marina rica en iodo, que se está usando en la medicina alternativa como laxante, diurético y como complemento en las dietas para perder peso. Caso clínico. Referimos el caso de un paciente varón de 60 años, diagnosticado de trastorno bipolar y en tratamiento con litio que simultáneamente tomaba una preparación herbal en la que se incluía el Fucus vesiculosus como laxante, y que desarrolló un hipertiroidismo que remitió una vez la preparación herbal fue retirada. Conclusiones. El Fucus vesiculosus puede producir hipertiroidismo debido a su alto contenido en iodo. Las preparaciones herbales deben ser tenidas en cuenta cuando tratamos a un paciente debido a la posibilidad de efectos adversos e interacciones con otros fármacos (AU)
Introduction. Fucus vesiculosus is a marine alga rich in iodine, which is being used in alternative medicine as a laxative, diuretic, and as a complement for weight loss diets. Case report. We report the case of a 60-year old male patient, diagnosed with bipolar disorder and under treatment with lithium concomitantly with a herbal preparation, including Fucus vesiculosus, as a laxative. He developed hyperthyroidism that remitted once the herbal preparation was withdrawn. Conclusion. Fucus vesiculosus may cause hyperthyroidism given its high iodine content. Herbal preparations should be taken in account when treating a patient due to the possibility of adverse effects and interactions with other drugs (AU)
Subject(s)
Humans , Male , Middle Aged , Hyperthyroidism/chemically induced , Fucus/toxicity , Lithium/therapeutic use , Bipolar Disorder/complications , Drug InteractionsABSTRACT
BACKGROUND: Fucoidan is a highly sulfated glycosaminoglycan, which has a molecular structure similar to that of heparin. The antithrombotic effects of fucoidan in vitro have been widely reported, but its antithrombotic effects in vivo as well as its other biological properties in vitro have not been well investigated. METHODS: This study investigated the effects and mechanism of fucoidan from Fucus vesiculosus on thrombosis both in vitro and in vivo. A ferric chloride-induced mouse carotid artery thrombosis model was used to determine the antithrombotic effects of fucoidan in vivo. Additionally, changes in the levels of proinflammatory cytokines and chemokines were examined in vascular cells treated with fucoidan. RESULTS: In vivo studies employing a ferric chloride-induced mouse carotid artery thrombosis model indicated that fucoidan had a stronger antithrombotic activity than heparin. Further, vascular cells treated with fucoidan demonstrated a decrease in proinflammatory cytokine and chemokine production as well as inhibition of proliferation. CONCLUSION: The major findings of this study showed that fucoidan has a stronger antithrombotic effect than heparin in vivo and that fucoidan has an inhibitory effect on proinflammatory cytokine production and proliferation of vascular cells.
Subject(s)
Animals , Mice , Carotid Artery Thrombosis , Chemokines , Cytokines , Fucus , Glycosaminoglycans , Heparin , Molecular Structure , Polysaccharides , ThrombosisABSTRACT
No disponible